News

FDAhighres

FDA approves palbociclib with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of HR-positive, HER2-positive metastatic breast cancer

25 June 2026
dna

Mapping the hidden rules of a key immune sensor

25 June 2026
PekelS_newsVisual3 - Credit: Daniela Velasco/EMBL

Large-scale microbiome study identifies robust colorectal cancer signature

25 June 2026
AI light

Light-based imaging offers hope in improving thyroid cancer diagnosis while reducing surgeries

25 June 2026
Combined hepatocellular-cholangiocarcinoma: A rare and challenging diagnostic entity – A Case Report - Credit Copyright: © 2026 Limaiem et al.

Rare combined liver cancer highlights challenges in diagnosis and treatment

25 June 2026
cyclin E1 overexpression in platinum-sensitive recurrent ovarian cancer

Scientists uncover how ovarian cancer resists chemotherapy — and how to reverse it

25 June 2026
advanced stage diagnosis of breast cancer in Ethiopia

TRAIL-R2 silencing linked to more aggressive breast cancer

25 June 2026
chest CT

Socioeconomic challenges colour patients’ lung cancer screening experience

25 June 2026
generic breast cancer

Fat tissue could explain triple negative breast cancer spread - and point to treatments

24 June 2026
generic doctor female

Fertility preservation care is still out of reach for many girls and young women with cancer, a Nursing Review finds

24 June 2026
mammogram

Changes in AI mammogram risk scores over time help predict future breast cancer

24 June 2026
Brain, connections, AI, artificial intelligence, neurotransmitter

Unlocking disease-linked protein changes using AI

24 June 2026
Back to Top